Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival

BackgroundIncreased expression of Eph receptor tyrosine kinases and their ephrin ligands has been implicated in tumor progression in a number of malignancies. This report describes aberrant expression of these genes in ovarian cancer, the commonest cause of death amongst gynaecological malignancies.MethodsEph and ephrin expression was determined using quantitative real time RT-PCR. Correlation of gene expression was measured using Spearman's rho statistic. Survival was analysed using log-rank analysis and (was visualised by) Kaplan-Meier survival curves.ResultsGreater than 10 fold over-expression of EphA1 and a more modest over-expression of EphA2 were observed in partially overlapping subsets of tumors. Over-expression of EphA1 strongly correlated (r = 0.801; p < 0.01) with the high affinity ligand ephrin A1. A similar trend was observed between EphA2 and ephrin A1 (r = 0.387; p = 0.06). A striking correlation of both ephrin A1 and ephrin A5 expression with poor survival (r = -0.470; p = 0.02 and r = -0.562; p < 0.01) was observed. Intriguingly, there was no correlation between survival and other clinical parameters or Eph expression.ConclusionThese data imply that increased levels of ephrins A1 and A5 in the presence of high expression of Ephs A1 and A2 lead to a more aggressive tumor phenotype. The known functions of Eph/ephrin signalling in cell de-adhesion and movement may explain the observed correlation of ephrin expression with poor prognosis.

[1]  A. Andres,et al.  Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. , 1998, Journal of cell science.

[2]  H. Hirai,et al.  Overexpression confers an oncogenic potential upon the eph gene. , 1990, Oncogene.

[3]  M. Kanamori,et al.  Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer , 2002, Journal of Cancer Research and Clinical Oncology.

[4]  L. Ellis,et al.  Coexpression of ephrin‐Bs and their receptors in colon carcinoma , 2002, Cancer.

[5]  H. Kuwano,et al.  EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma , 2003, International journal of cancer.

[6]  M. Yoshida,et al.  Evolution, expression, and chromosomal location of a novel receptor tyrosine kinase gene, eph , 1988, Molecular and cellular biology.

[7]  M. Lackmann,et al.  Signals from Eph and Ephrin Proteins: A Developmental Tool Kit , 2001, Science's STKE.

[8]  Ke Chen,et al.  Characterization of the EphA1 Receptor Tyrosine Kinase: Expression in Epithelial Tissues , 2001, Growth factors.

[9]  H-C Chen,et al.  Tyrosine-kinase expression profiles in human gastric cancer cell lines and their modulations with retinoic acids , 2003, British Journal of Cancer.

[10]  H. Hirai,et al.  A novel putative tyrosine kinase receptor encoded by the eph gene. , 1987, Science.

[11]  P. Hewett,et al.  Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer , 2001, BMC Molecular Biology.

[12]  D. Cerretti,et al.  LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain. , 1997, Cytokine.

[13]  E. Pasquale,et al.  Eph receptors and ephrin ligands: embryogenesis to tumorigenesis , 2000, Oncogene.

[14]  L. Akslen,et al.  Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression. , 2002, The American journal of pathology.

[15]  R. Klein.  Bidirectional signals establish boundaries. , 1999, Current biology : CB.

[16]  Tony Pawson,et al.  β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.

[17]  R. Klein.  Neural development: Bidirectional signals establish boundaries , 1999, Current Biology.

[18]  M. Herlyn,et al.  Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. , 1995, Cancer research.

[19]  M. Göke,et al.  Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[20]  H. Clevers,et al.  Live and let die in the intestinal epithelium. , 2004, Current opinion in cell biology.

[21]  A. Bergemann,et al.  Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis , 2002, Microscopy research and technique.

[22]  M. Kinch,et al.  EphA2 overexpression causes tumorigenesis of mammary epithelial cells. , 2001, Cancer research.

[23]  J. Nesland,et al.  The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas. , 2005, Gynecologic oncology.

[24]  D. Harpole,et al.  Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  M. Lackmann,et al.  The role of the Eph-ephrin signalling system in the regulation of developmental patterning. , 2002, The International journal of developmental biology.

[26]  E. Dreher,et al.  Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. , 2002, Oncology reports.

[27]  H. Kung,et al.  A tyrosine kinase profile of prostate carcinoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Kullander,et al.  Mechanisms and functions of eph and ephrin signalling , 2002, Nature Reviews Molecular Cell Biology.

[29]  A. Flenniken,et al.  Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during Embryogenesis , 1996, Neuron.